Peer Reviewed
Drug update
Lercanidipine and enalapril combination therapy for the treatment of hypertension
Recent articles on:
Hypertension
Hypertension
Recent articles on:
Antihypertensive medicines
Antihypertensive medicines
Abstract
Lercanidipine plus enalapril (Zan-Extra) has been approved for use in patients with hypertension who have not reached blood pressure targets after treatment with either lercanidipine or enalapril monotherapy.
Key Points
What is lercanidipine plus enalapril combination therapy?
Lercanidipine plus enalapril (Zan-Extra) is a fixed dose combination antihypertensive medication, which consists of the dihydropyridine calcium channel blocker lercanidipine (Zanidip) and the angiotensin converting enzyme (ACE) inhibitor enalapril. There are two doses available: lercanidipine 10 mg plus enalapril 10 mg (Zan-Extra 10/10) and lercanidipine 10 mg plus enalapril 20 mg (Zan-Extra 10/20).
Purchase the PDF version of this article
Already a subscriber? Login here.